ResearcherShenyang Pharmaceutical UniversityNo recent work listed

Yongjun Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2801-4573; OpenAlex author ID A5100424206. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2021: 1 paper

Papers 1

Irinotecan and berberine co-delivery liposomes showed improved efficacy and reduced intestinal toxicity compared with Onivyde for pancreatic cancer. Last author DOI 10.1007/s13346-020-00884-4 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xue Bing Wang · 1 shared paper, 2021 · strength 0.13
- Paper Irinotecan and berberine co-delivery liposomes showed improved efficacy and reduced intestinal toxicity compared with O… DOI 10.1007/s13346-020-00884-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.